Skip to main content
main-content

12-09-2017 | Audio

Bevacizumab in cervical cancer

The phase III GOG 240 trial evaluated bevacizumab in women with advanced cervical cancer - Advisory Board member and lead investigator Krishnansu Tewari outlines the results of the final analysis in this podcast.